IGF1-LR3

IGF1-LR3 (Long R3 Insulin-like Growth Factor-1) is a research-grade analog of native IGF‑1 engineered for higher potency and a prolonged half-life, making it a powerful tool for studies on muscle growth, tissue repair, and metabolic regulation. Structural modifications reduce its binding to IGF‑binding proteins, allowing more peptide to reach target tissues and sustain receptor activation.

Anabolic And Muscle Research

• Enhances activation of the PI3K/Akt/mTOR pathway in muscle cells, increasing protein synthesis while reducing protein breakdown, which is central to studies on hypertrophy and preservation of lean mass.

• Stimulates satellite cell activation and proliferation, supporting research into accelerated muscle repair, regeneration after injury, and mitigation of age-related muscle loss and cachexia.

Recovery, Tissue Repair, And Performance

• Promotes cell proliferation and myofibril reconstruction in damaged tissues, shortening recovery time and improving structural integrity of repaired muscle and connective tissue in preclinical models.

• Improves glucose uptake and nutrient partitioning into muscle, making it relevant for experiments on body recomposition, performance recovery, and insulin-sensitizing strategies.

For research purposes only. Not intended for human consumption, medical treatment, or veterinary use.